Literature DB >> 12234810

Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts.

Heather R Cross1, Elizabeth Murphy, Richard G Black, John Auchampach, Charles Steenbergen.   

Abstract

To determine whether A(3) adenosine receptor (A(3)AR) signaling modulates myocardial function, energetics, and cardioprotection, hearts from wild-type and A(3)AR-overexpressor mice were subjected to 20-min ischemia and 40-min reperfusion while (31)P NMR spectra were acquired. Basal heart rate and left ventricular developed pressure (LVDP) were lower in A(3)AR-overexpressor hearts than wild-type hearts. Ischemic ATP depletion was delayed and postischemic recoveries of contractile function, ATP, and phosphocreatine were greater in A(3)AR-hearts. To determine the role of depressed heart rate and to confirm A(3)AR-specific signaling, hearts were paced at 480 beats/min with or without 60 nmol/l MRS-1220 (A(3)AR-specific inhibitor) and then subjected to ischemia-reperfusion. LVDP was similar in paced A(3)AR-overexpressor and paced wild-type hearts. Differences in ischemic ATP depletion and postischemic contractile and energetic dysfunction remained in paced A(3)AR-overexpressor hearts versus paced wild-type hearts but were abolished by MRS-1220. In summary, A(3)AR overexpression decreased basal heart rate and contractility, preserved ischemic ATP, and decreased postischemic dysfunction. Pacing abolished the decreased contractility but not the ATP preservation or cardioprotection. Therefore, A(3)AR overexpression results in cardioprotection via a specific A(3)AR effect, possibly involving preservation of ATP during ischemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234810      PMCID: PMC3934563          DOI: 10.1152/ajpheart.00335.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  32 in total

1.  Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.

Authors:  J A Auchampach; A Rizvi; Y Qiu; X L Tang; C Maldonado; S Teschner; R Bolli
Journal:  Circ Res       Date:  1997-06       Impact factor: 17.367

2.  Preconditioning of human myocardium with adenosine during coronary angioplasty.

Authors:  M A Leesar; M Stoddard; M Ahmed; J Broadbent; R Bolli
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

3.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.

Authors:  J Strickler; K A Jacobson; B T Liang
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

5.  Invasive hemodynamics and force-frequency relationships in open- versus closed-chest mice.

Authors:  B D Hoit; N Ball; R A Walsh
Journal:  Am J Physiol       Date:  1997-11

6.  A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.

Authors:  K Stambaugh; K A Jacobson; J L Jiang; B T Liang
Journal:  Am J Physiol       Date:  1997-07

7.  Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart.

Authors:  W R Tracey; W Magee; H Masamune; S P Kennedy; D R Knight; R A Buchholz; R J Hill
Journal:  Cardiovasc Res       Date:  1997-02       Impact factor: 10.787

8.  Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion.

Authors:  J P Headrick; N S Gauthier; S S Berr; R R Morrison; G P Matherne
Journal:  J Mol Cell Cardiol       Date:  1998-05       Impact factor: 5.000

9.  Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice.

Authors:  H R Cross; L Lu; C Steenbergen; K D Philipson; E Murphy
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

10.  Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts.

Authors:  C P de Albuquerque; G Gerstenblith; R G Weiss
Journal:  Circ Res       Date:  1994-01       Impact factor: 17.367

View more
  16 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

2.  Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.

Authors:  Tung O Chan; Hajime Funakoshi; Jianliang Song; Xue-Qian Zhang; JuFang Wang; Paul H Chung; Brent R DeGeorge; Xue Li; Jin Zhang; David E Herrmann; Maura Diamond; Eman Hamad; Steven R Houser; Walter J Koch; Joseph Y Cheung; Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

3.  Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Susanna Tchilibon; Heng T Duong; Bhalchandra V Joshi; Dmitry Sonin; Bruce T Liang
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

4.  CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.

Authors:  S Cohen; S M Stemmer; G Zozulya; A Ochaion; R Patoka; F Barer; S Bar-Yehuda; L Rath-Wolfson; K A Jacobson; P Fishman
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

5.  Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.

Authors:  Leo M Gazoni; Dustin M Walters; Eric B Unger; Joel Linden; Irving L Kron; Victor E Laubach
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-15       Impact factor: 5.209

Review 6.  Magnetic resonance imaging and spectroscopy of the murine cardiovascular system.

Authors:  Ashwin Akki; Ashish Gupta; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-04       Impact factor: 4.733

7.  Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning.

Authors:  Mourad Ogbi; John A Johnson
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 8.  Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man.

Authors:  Arthur M Feldman; Ellina Cheksis-Feiner; Eman Hamad; Tung Chan
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

9.  Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.

Authors:  Bella Chanyshev; Asher Shainberg; Ahuva Isak; Alexandra Litinsky; Yelena Chepurko; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Edith Hochhauser; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2011-12-01       Impact factor: 7.658

10.  Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model.

Authors:  Jesper van der Pals; Sasha Koul; Michael I Götberg; Göran K Olivecrona; Martin Ugander; Mikael Kanski; Andreas Otto; Matthias Götberg; Håkan Arheden; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2010-01-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.